I

    Insulet Corporation (PODD)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $148.66
    +3.53 (+2.43%)

    Market Cap: $10.31B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    73%(29/40)
    Avg Surprise
    +85.63%
    Streak
    8 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.59
    Range$1.50 - $1.66
    21 analysts
    EPS Revisions
    3
    0
    7d
    3
    16
    30d
    EPS Estimate Drift
    90d ago$1.64+3.3%
    60d ago$1.64+3.3%
    30d ago$1.64+3.1%
    7d ago$1.60+0.6%
    Current$1.59
    Revenue Consensus
    $833M
    Range$826M - $838M
    22 analysts
    Period ending Dec 31, 2026
    EPS Consensus$2.27
    Range$2.18 - $2.34
    23 analysts
    Revenue Consensus
    $937M
    Range$840M - $951M
    25 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$2.27---
    Sep 26EST
    		-$1.59---
    Jun 26
    Reported Aug 5
    		$1.66$1.44+15.28%Beat+41.9%
    Mar 26
    Reported May 6
    		$1.42$1.19+19.33%Beat+39.2%
    Dec 25
    Reported Feb 18
    		$1.55$1.48+4.73%Beat+34.8%
    Sep 25
    Reported Nov 6
    		$1.24$1.15+7.83%Beat+37.8%
    Jun 25
    Reported Aug 7
    		$1.17$0.93+25.81%Beat+112.7%
    Mar 25
    Reported May 8
    		$1.02$0.79+29.11%Beat+39.7%
    Dec 24
    Reported Feb 20
    		$1.15$1.02+12.63%Beat-17.9%
    Sep 24
    Reported Nov 7
    		$0.90$0.76+18.42%Beat+26.8%
    Jun 24
    Reported Aug 8
    		$0.55$0.56-1.79%Miss+44.7%
    Mar 24
    Reported May 9
    		$0.73$0.39+87.18%Beat+217.4%
    Dec 23
    Reported Feb 22
    		$1.40$0.66+112.12%Beat+483.3%
    Sep 23
    Reported Nov 2
    		$0.71$0.41+73.17%Beat+73.2%
    Jun 23
    Reported Aug 8
    		$0.38$0.26+46.15%Beat+575.0%
    Mar 23
    Reported May 4
    		$0.23$0.10+130.00%Beat-42.5%
    Dec 22
    Reported Feb 23
    		$0.24$0.21+14.29%Beat-42.9%
    Sep 22
    Reported Nov 3
    		$0.41$0.14+192.86%Beat+105.0%
    Jun 22
    Reported Aug 4
    		$-0.08N/A-134.78%Miss-153.3%
    Mar 22
    Reported May 5
    		$0.40$0.24+66.67%Beat-
    Dec 21
    Reported Feb 23
    		$0.42$0.32+31.25%Beat+1150.0%
    Sep 21
    Reported Nov 4
    		$0.20$0.25-20.00%Miss+17.6%
    Jun 21
    Reported Aug 5
    		$0.15$0.14+7.14%Beat-31.8%
    Mar 21
    Reported May 6
    		$0.00N/A-100.00%Miss+100.0%
    Dec 20
    Reported Feb 23
    		$-0.04$-0.04+0.00%Beat-140.0%
    Sep 20
    Reported Nov 4
    		$0.17$0.08+112.50%Beat+88.9%
    Jun 20
    Reported Aug 6
    		$0.22$0.01+2100.00%Beat+1000.0%
    Mar 20
    Reported May 7
    		$-0.03$-0.01-200.00%Miss-142.9%
    Dec 19
    Reported Feb 25
    		$0.10$0.12-16.67%Miss-37.5%
    Sep 19
    Reported Nov 5
    		$0.09$0.04+125.00%Beat+200.0%
    Jun 19
    Reported Aug 5
    		$0.02$0.03-33.33%Miss+166.7%
    Mar 19
    Reported May 2
    		$0.07$0.01+600.00%Beat+163.6%
    Dec 18
    Reported Feb 25
    		$0.16$0.07+128.57%Beat+233.3%
    Sep 18
    Reported Nov 1
    		$0.03$0.03+0.00%Beat+175.0%
    Jun 18
    Reported Aug 2
    		$-0.03N/A+76.92%Beat+76.9%
    Mar 18
    Reported May 3
    		$-0.11$-0.18+38.89%Beat+35.3%
    Dec 17
    Reported Feb 21
    		$-0.12$-0.08-50.00%Miss+25.0%
    Sep 17
    Reported Nov 2
    		$-0.04N/A+60.00%Beat-300.0%
    Jun 17
    Reported Aug 3
    		$-0.13$-0.12-8.33%Miss-
    Mar 17
    Reported May 8
    		$-0.17$-0.15-13.33%Miss-
    Dec 16
    Reported Feb 27
    		$-0.16$-0.05-220.00%Miss-
    Sep 16
    Reported Nov 3
    		$-0.01N/A+87.50%Beat-

    Key Metrics

    Valuation
    P/E Ratio25.33EV/EBITDA15.87x
    Price/FCF37.57xFCF Yield2.66%
    Profitability
    Profit Margin12.30%Operating Margin16.20%
    ROE26.00%ROIC16.98%
    Financial Health
    Debt/Equity0.67xInterest Coverage9.02x
    Current Ratio2.48xQuick Ratio1.83x
    Trading Statistics
    Beta1.09Avg Volume2.03M
    52-Week High$354.8852-Week Low$126.40

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$146.36
    SMA 20$145.31
    SMA 50$154.14
    SMA 200$213.88
    EMA 10$145.96
    EMA 20$147.83
    EMA 50$153.46
    EMA 200$200.05

    MACD

    Line: -2.75Signal: -3.24Hist: 0.48

    ADX

    ADX: 16.6+DI: 24.3-DI: 25.4

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down28.0
    PSAR$158.73

    Bollinger Bands

    Upper Band$158.16
    Lower Band$132.46
    %B Position1769%(Upper)
    Band Width0.63

    RSI (14-Day)

    Neutral
    49.4

    Momentum Oscillators

    Stoch %K44.1
    Stoch %D39.9
    Williams %R-38.5
    ROC (10d)6.4%
    Momentum8.96
    CCI (20d)29.8
    MFI (14d)49.0

    Volatility Measures

    ATR (14d)$6.35(4.3%)
    StdDev (20d)6.43
    Hist Vol81.8%(High)

    Volume Flow

    VWAP$146.78
    OBV1.1M
    AD Line7.1M
    CMF (20d)0.271

    Volume Metrics

    Avg Vol (20d)2.1M
    Vol Ratio3.2x(High)
    VWMA (20d)$143.82

    Pivot Points

    R3$149.46
    R2$148.07
    R1$146.60
    Pivot Point$145.20
    S1$143.73
    S2$142.34
    S3$140.87

    Advanced Oscillators

    TSI-10.68
    Ultimate Osc52.0
    KST-80.09

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$801.70M$761.70M$783.70M$706.30M$649.10M$569.00M$597.50M$543.90M$488.50M$441.70M$509.80M$432.70M
    Cost of Revenue$239.10M$232.70M$215.10M$196.20M$196.90M$159.90M$166.60M$166.80M$157.60M$134.90M$148.60M$139.40M
    Gross Profit$562.60M$529.10M$568.60M$510.10M$452.20M$409.00M$430.90M$377.10M$330.90M$306.80M$361.20M$293.30M
    Operating Expenses$432.90M$406.90M$422.40M$392.40M$331.10M$320.30M$321.50M$289.00M$276.40M$249.90M$254.70M$238.50M
    R&D$88.10M$89.70M$90.90M$77.20M$73.40M$59.60M$60.60M$54.90M$53.90M$50.20M$42.00M$57.80M
    SG&A$344.80M$317.20M$331.50M$315.20M$257.70M$260.70M$260.90M$234.10M$222.50M$199.70M$212.70M$180.70M
    Operating Income$129.70M$122.10M$146.20M$117.70M$121.10M$88.80M$109.40M$88.10M$54.50M$56.90M$106.50M$54.80M
    Interest Income$3.60M$4.90M$5.70M$8.60M$10.10M$10.30M$10.30M$10.50M$9.30M$9.40M$6.20M$8.60M
    Interest Expense$13.50M$14.70M$15.00M$15.60M$104.00M$48.70M$8.60M$12.40M$11.00M$10.70M$6.70M$10.40M
    Income Before Tax$118.70M$113.00M$140.20M$122.80M$28.40M$48.20M$111.30M$82.90M$51.10M$54.90M$107.90M$53.70M
    Income Tax Expense$23.70M$21.90M$38.60M$35.20M$5.90M$12.70M$10.60M$5.40M$-137,500,000$3.40M$4.50M$1.80M
    Net Income$95.00M$91.10M$101.60M$87.60M$22.50M$35.40M$100.70M$77.50M$188.60M$51.50M$103.30M$51.90M
    EBITDA$156.00M$149.70M$174.60M$152.60M$146.80M$110.80M$133.20M$107.60M$73.70M$77.00M$129.30M$75.80M
    EBIT$128.60M$122.80M$149.40M$129.80M$122.40M$86.60M$109.80M$84.70M$52.70M$56.20M$108.40M$55.50M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PODD

    News

    PODD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Insulet Corporation Investors Have Opportunity to Lead Class Action Lawsuit!

    Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Insulet Corporation (NASDAQ: PODD) and its officers. The lawsuit alleges that Insulet made materially false and misleading statements regarding its business, operations, and compliance policies between May 21, 2025, and May 26, 2026, specifically concerning defective manufacturing controls. Investors who suffered losses have until August 31, 2026, to request to be appointed lead plaintiff, with the firm offering representation on a contingency fee basis.

    ACCESS Newswire•8/29/26•
    Bearish

    Insulet Corp. stock outperforms competitors on strong trading day

    Insulet Corp. (PODD) saw its stock rise by 1.20% to $145.13 on Friday, marking its third consecutive day of gains. This performance occurred on a challenging trading day where the S&P 500 Index and Dow Jones Industrial Average both experienced declines. The company's stock outperformed the broader market.

    MarketWatch•8/28/26•
    Bullish

    Insulet Deadline: PODD Investors with Losses in Excess of $100K Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit

    The Rosen Law Firm is reminding investors of Insulet Corporation (NASDAQ: PODD) who suffered losses exceeding $100,000 between February 21, 2025, and May 26, 2026, of the August 31, 2026 deadline to apply to be lead plaintiff in a securities fraud lawsuit. The lawsuit alleges that Insulet made false or misleading statements regarding defective manufacturing controls and procedures that created a heightened risk of safety violations or injury. Investors are encouraged to contact the firm for information on joining the class action.

    PR Newswire•8/28/26•
    Bearish

    INSULET CORPORATION DEADLINE MONDAY AUGUST 31st: Bragar

    Bragar Eagel & Squire, P.C. has announced a class action lawsuit against Insulet Corporation (NASDAQ:PODD) for alleged false and misleading statements regarding defective manufacturing controls between February 21, 2025, and May 26, 2026. Investors who purchased Insulet securities during this period and suffered losses are urged to contact the firm before the lead plaintiff deadline of August 31, 2026. The lawsuit claims that Insulet's defective controls posed a risk of safety regulation violations and injury.

    GlobeNewswire•8/28/26•
    Bearish

    PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with SBS Law

    Schall, Brown & Schwartz LLP (SBS) is reminding investors of a class action lawsuit against Insulet Corporation (NASDAQ: PODD) for alleged securities fraud. The lawsuit claims Insulet made false statements regarding defective manufacturing controls, which led to increased safety violation risks and impacted more of its Pod Products than disclosed. Investors who purchased shares between February 21, 2025, and May 26, 2026, are encouraged to contact SBS before the August 31, 2026, deadline to discuss potentially leading the lawsuit.

    GlobeNewswire•8/28/26•
    Bearish

    Frequently Asked Questions About PODD

    Does PODD pay dividends?
    Insulet Corporation (PODD) does not currently pay a regular dividend.
    What is PODD's P/E ratio?
    Insulet Corporation has a price-to-earnings (P/E) ratio of 25.33.
    What is PODD's market cap?
    Insulet Corporation (PODD) has a market capitalization of $10.31B with a current stock price of $148.66.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In